Home
Conditions
Malaria, Vivax

Clinical trial condition

Malaria, Vivax

Explore clinical trials studying Malaria, Vivax. Study availability and eligibility vary by location and protocol.

34 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Malaria, Vivax trial results

Completed

Study to Assess the Incidence of Hemolysis, Safety, and Efficacy of Tafenoquine (SB-252263, WR238605) Versus Primaquine in Subjects With Plasmodium Vivax Malaria

NCT02216123

Conditions: Disease Attributes, Hemolysis, Infections, +9 more
Locations: GSK Investigational Site Manaus, Amazonas, Brazil

GSK Investigational Site Cali, Colombia

GSK Investigational Site Montería, Colombia

GSK Investigational Site Gonder, Ethiopia

View Trial Details

Completed

Ph 2B/3 Tafenoquine (TFQ) Study in Prevention of Vivax Relapse

NCT01376167

Conditions: Infections, Malaria, Malaria, Vivax, +4 more
Locations: GSK Investigational Site Bāndarban, Bangladesh

GSK Investigational Site Manaus, Amazonas, Brazil

GSK Investigational Site Porto Velho, Rondônia, Brazil

GSK Investigational Site Oddar Meancheay Province, Cambodia

View all 14 locations

View Trial Details

Completed

Assessment of Any Potential Retinal Effects of Tafenoquine (TQ)

NCT02658435

Conditions: Infections, Malaria, Malaria, Vivax, +4 more
Locations: GSK Investigational Site Glendale, California, United States

GSK Investigational Site Overland Park, Kansas, United States

GSK Investigational Site Baltimore, Maryland, United States

View Trial Details

Completed

A Study to Evaluate the Pharmacokinetics of a Single Dose of Tafenoquine Co-administered With Either Artemether + Lumefantrine or Dihydroartemisinin + Piperaquine Tetraphosphate

NCT02184637

Conditions: Infections, Malaria, Malaria, Vivax, +4 more
Locations: GSK Investigational Site Baltimore, Maryland, United States

View Trial Details

Completed

Tafenoquine Thorough QTc Study in Healthy Subjects

NCT01928914

Conditions: Infections, Malaria, Malaria, Vivax, +4 more
Locations: GSK Investigational Site Culver City, California, United States

GSK Investigational Site Baltimore, Maryland, United States

View Trial Details

Completed

A Study to Assess the Effects of Dissolution Profile on the Pharmacokinetics of Single Oral Doses of Tafenoquine Tablets and Tafenoquine Stable Isotope Labelled Solution

NCT02751294

Conditions: Infections, Malaria, Malaria, Vivax, +4 more
Locations: GSK Investigational Site Baltimore, Maryland, United States

View Trial Details

Completed

Efficacy of Chloroquine (CQ) Alone Compared to Concomitant CQ and Primaquine for Plasmodium Vivax Infection

NCT02691910

Conditions: Infections, Malaria, Malaria, Vivax, +4 more
Locations: Oswaldo Cruz Foundation Rio de Janeiro, Brazil

Institute of Biomedical Sciences, University of Sao Paulo São Paulo, Brazil

View Trial Details

Completed

Efficacy, Tolerability, PK of OZ439 in Adults With Acute, Uncomplicated P.Falciparum or Vivax Malaria Mono-infection

NCT01213966

Conditions: Infections, Malaria, Malaria, Falciparum, +5 more
Locations: Not specified

View Trial Details

Completed

Pilot Human Study of Tinidazole Efficacy For Radical Cure Of Plasmodium Vivax

NCT00811096

Conditions: Disease Attributes, Infections, Malaria, +8 more
Locations: Malaria Research Unit, 68/30 Ban Toong Road, P.O. Box 46 Mae Sot, Changwat Tak, Thailand

View Trial Details

Completed

Therapeutic Efficacy Study of Pyrimethamine/Sulfdoxine (Fansidar®) for the Treatment of Uncomplicated Falciparum Malaria in the Peruvian Amazon

NCT00951106

Conditions: Infections, Malaria, Malaria, Falciparum, +5 more
Locations: Naval Medical Research Center Detachment Lima, Peru

View Trial Details

Malaria, Vivax

Malaria, Vivax trial results

Related conditions